Get the Stockscreener App
47.85
0.03%
0.12
Livanova Plc stock is traded at $47.85, with a volume of 323.85K.
It is up +0.03% in the last 24 hours and up +2.03% over the past month.
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$47.97
Open:
$48.07
24h Volume:
323.85K
Relative Volume:
0.70
Market Cap:
$2.60B
Revenue:
$1.24B
Net Income/Loss:
$23.68M
P/E Ratio:
113.93
EPS:
0.42
Net Cash Flow:
$108.67M
1W Performance:
-3.93%
1M Performance:
+2.03%
6M Performance:
+7.35%
1Y Performance:
-3.04%
1-Day Range:
$47.91
$48.42
1-Week Range:
$47.48
$49.54
52-Week Range:
$43.15
$64.47
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
48.03 | 2.60B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
129.19 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.86 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
393.47 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.07 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.29 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
KBC Group NV Purchases 56,580 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova (NASDAQ:LIVN) Given "Buy" Rating at Needham & Company LLC - MarketBeat
Heart Valves Tester Market Surging Forward at 8.18% CAGR, Reaching 11.4 Billion USD by 2032 | Jotec GmbH, - EIN News
Getinge exits surgical perfusion, creating opportunity for Livanova - MedTech Dive
Cardiovascular Devices Market Detailed in New Research Report By 2032 | Livanova PLC, B. Braun Melsungen AG - openPR
Defibrillators Market registering a CAGR of 6.6% from 2021 - openPR
Stifel maintains LivaNova stock Buy rating, $72 target By Investing.com - Investing.com Australia
Stifel maintains LivaNova stock Buy rating, $72 target - MSN
Medical Implants Market Projected To Garner Significant Growth by 2024 -2031:Biotronik, Inc, Livanova Plc, - EIN News
(LIVN) On The My Stocks Page - Stock Traders Daily
Artificial Heart Valve Market Trends is Electrifying Growth Cycle: Medtronic, LivaNova, CryoLife - openPR
Investor Network: Livanova PLC to Host Earnings Call - ACCESS Newswire
LivaNova (NASDAQ:LIVN) shareholders have endured a 35% loss from investing in the stock three years ago - Simply Wall St
Should You Sell LivaNova PLC (LIVN)? - Insider Monkey
LivaNova (NASDAQ:LIVN) Downgraded by StockNews.com to Buy - Defense World
LivaNova (NASDAQ:LIVN) Stock Rating Lowered by StockNews.com - MarketBeat
Vagus Nerve Stimulators Market is Estimated to Grow at a CAGR - openPR
Brokerages Set LivaNova PLC (NASDAQ:LIVN) PT at $69.17 - MarketBeat
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results - Business Wire
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - MSN
LivaNova Sets Date for Q4 and Full-Year 2024 Earnings Release and Conference Call - StockTitan
LIVN (LivaNova) EV-to-EBITDA : 53.85 (As of Jan. 20, 2025) - GuruFocus.com
Vagus Nerve Stimulators Market Growth in Future Scope 2025-2032 - openPR
StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to Strong-Buy - MarketBeat
JPMorgan Chase & Co. Lowers Stock Position in LivaNova PLC (NASDAQ:LIVN) - Defense World
42,185 Shares in LivaNova PLC (NASDAQ:LIVN) Purchased by Harbor Capital Advisors Inc. - MarketBeat
Nordea Investment Management AB Acquires 12,470 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC appoints Natalia Kozmina as Chief Human Resources Officer - ETHRWorld Middle East
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer - Business Wire
Electroceuticals Market Top Companies StudyMedtronic Plc - openPR
Principal Financial Group Inc. Has $9.01 Million Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Sanctuary Advisors LLC Acquires Shares of 4,268 LivaNova PLC (NASDAQ:LIVN) - Defense World
LivaNova PLC's (NASDAQ:LIVN) Price Is Right But Growth Is Lacking - Simply Wall St
LivaNova PLC (NASDAQ:LIVN) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
(LIVN) Investment Report - Stock Traders Daily
LivaNova (NASDAQ:LIVN) Lowered to Buy Rating by StockNews.com - MarketBeat
Vagus Nerve Stimulators Market Growth in Future Scope 2024-2031 - openPR
Vagus Nerve Stimulators Market Report Analysis and Research - openPR
LivaNova's Depression Treatment Study Shows Promise Despite Mixed Clinical Results - StockTitan
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression - Business Wire
StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to "Strong-Buy" - MarketBeat
State Street Corp Cuts Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Fmr LLC Has $1.65 Million Stock Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Captrust Financial Advisors Buys Shares of 4,133 LivaNova PLC (NASDAQ:LIVN) - Defense World
When (LIVN) Moves Investors should Listen - Stock Traders Daily
LivaNova's SWOT analysis: sleep apnea platform could awaken stock potential - Investing.com India
Jane Street Group LLC Sells 19,525 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Shares Sold by Barclays PLC - MarketBeat
XTX Topco Ltd Invests $550,000 in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Insider Sell: Francesco Bianchi Sells 1,250 Shares of LivaNova P - GuruFocus.com
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Livanova Plc Stock (LIVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Poletti Franco | President, Cardiopulmonary |
Dec 15 '24 |
Option Exercise |
0.00 |
967 |
0 |
7,634 |
| Barry James Christopher | Director |
Dec 15 '24 |
Option Exercise |
0.00 |
1,709 |
0 |
1,709 |
| Shvartsburg Alex | Chief Financial Officer |
Dec 15 '24 |
Option Exercise |
0.00 |
613 |
0 |
19,342 |
| Bianchi Francesco | Director |
Dec 11 '24 |
Sale |
50.99 |
1,250 |
63,738 |
7,522 |
1.21%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):